Beranda › Gumpalan Darah › Michigan
Uji klinis Gumpalan Darah di Michigan
6 studi untuk Gumpalan Darah mencari peserta di lokasi di Michigan.
Kota di Michigan
Teks studi resmi (Bahasa Inggris)
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Profound Research, Cardiology and Vascular Associates (CAVA) - Bloomfield Hills, Bloomfield Hills
- Profound Research, Millennium Cardiology, Farmington Hills
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07626411Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- Profound Research, Millennium Cardiology, Farmington Hills
- AA Medical Research Center (MRC), Flint
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07175428Aspiration Thrombectomy Using the Symphony or Prodigy System
- Henry Ford Hospital, Detroit
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07350499Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- Profound Research, Cardiology and Vascular Associates (CAVA) - Bloomfield Hills, Bloomfield Hills
- Profound Research, Millennium Cardiology, Farmington Hills
- AA Medical Research Center (MRC), Flint
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07430956ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Central Michigan Children's Hospital of Michigan, Detroit
- Henry Ford Health System Bleeding and Thrombosis Treatment Center, Detroit
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT04398628Michigan Initial Experience Using Tigertriever for Thrombectomy
- Henry Ford Hospital, Detroit
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Mei 2026 · NCT07363525Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.